Cargando…
Molnupiravir Revisited—Critical Assessment of Studies in Animal Models of COVID-19
Molnupiravir, a prodrug known for its broad antiviral activity, has demonstrated efficacy in animal models of COVID-19, prompting clinical trials, in which initial results indicated a significant effect against the disease. However, subsequent clinical studies did not confirm these findings, leading...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675540/ https://www.ncbi.nlm.nih.gov/pubmed/38005828 http://dx.doi.org/10.3390/v15112151 |